On Tuesday, Axsome Therapeutics Inc (NASDAQ: AXSM) opened higher 2.78% from the last session, before settling in for the closing price of $71.10. Price fluctuations for AXSM have ranged from $55.02 to $98.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 88.16%. Company’s average yearly earnings per share was noted 30.36% at the time writing. With a float of $38.78 million, this company’s outstanding shares have now reached $47.35 million.
The extent of productivity of a business whose workforce counts for 545 workers is very important to gauge.
Axsome Therapeutics Inc (AXSM) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Axsome Therapeutics Inc is 18.14%, while institutional ownership is 80.86%. The most recent insider transaction that took place on Apr 01 ’24, was worth 1,904,942. In this transaction Chief Operating Officer of this company sold 24,662 shares at a rate of $77.24, taking the stock ownership to the 0 shares. Before that another transaction happened on Mar 15 ’24, when Company’s Director sold 2,347 for $71.61, making the entire transaction worth $168,062. This insider now owns 120,756 shares in total.
Axsome Therapeutics Inc (AXSM) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 30.36% per share during the next fiscal year.
Axsome Therapeutics Inc (NASDAQ: AXSM) Trading Performance Indicators
Check out the current performance indicators for Axsome Therapeutics Inc (AXSM). In the past quarter, the stock posted a quick ratio of 3.52. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.20, a number that is poised to hit -1.18 in the next quarter and is forecasted to reach 0.86 in one year’s time.
Technical Analysis of Axsome Therapeutics Inc (AXSM)
The latest stats from [Axsome Therapeutics Inc, AXSM] show that its last 5-days average volume of 0.67 million was inferior to 0.73 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 66.15%. Additionally, its Average True Range was 3.33.
During the past 100 days, Axsome Therapeutics Inc’s (AXSM) raw stochastic average was set at 23.04%, which indicates a significant decrease from 79.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.92% in the past 14 days, which was lower than the 51.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $76.94, while its 200-day Moving Average is $74.81. Now, the first resistance to watch is $74.85. This is followed by the second major resistance level at $76.61. The third major resistance level sits at $78.89. If the price goes on to break the first support level at $70.81, it is likely to go to the next support level at $68.53. The third support level lies at $66.77 if the price breaches the second support level.
Axsome Therapeutics Inc (NASDAQ: AXSM) Key Stats
There are currently 47,374K shares outstanding in the company with a market cap of 3.46 billion. Presently, the company’s annual sales total 270,600 K according to its annual income of -239,240 K. Last quarter, the company’s sales amounted to 71,530 K and its income totaled -98,650 K.
